FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy

Takashi Yoshioka, Hiroshi Fukuda, Takehiko Fujiwara, Ren Iwata, Tatuo Ido, Yasuko Murakawa, Makio Gamo, Chikashi Ishioka, Ryunosuke Kanamaru

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Fluorine-18-2-deoxy-2-fluoro-D-glucose (F-18 FDG) PET may be more suitable for follow-up after cancer treatment than other morphologic approaches, because it reflects tumor viability. A patient with abdominal lymph node metastases from colon cancer was followed by CT and F-18 FDG PET during chemotherapy. F-18 FDG PET tumor images changed in accordance with the clinical progress, whereas CT findings were relatively unchanged. This case clearly shows the utility of F-18 FDG PET for follow-up during cancer chemotherapy.

Original languageEnglish
Pages (from-to)261-263
Number of pages3
JournalClinical Nuclear Medicine
Volume24
Issue number4
DOIs
Publication statusPublished - 1999 Apr

Keywords

  • Chemotherapy
  • Fluorine-18-2-deoxy-2-fluoro-D-glucose
  • Positron Emission Tomography
  • Recurrence
  • Residue

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy'. Together they form a unique fingerprint.

Cite this